Samsung Biologics Inks Deal to Mass-Produce COVID-19 Treatment
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
Samsung Biologics announced on Thursday that it signed with Vir Biotechnology Inc. a manufacturing agreement worth approximately $362 million (438 ...
142 total views, 2 views today
153 total views, 1 views today
134 total views, 3 views today
412 total views, 11 views today
122 total views, 3 views today
151 total views, 2 views today
126 total views, 2 views today
93 total views, 5 views today
120 total views, 1 views today
113 total views, 2 views today
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |
Copyright © 2020 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy|Contact : [email protected] |